Table 2 Comparison of composite outcomes in the published literature
Study name | Single vessel LAD revascularisation | Number of patients | Peri-operative MACE | Secondary outcomes | 30 day MACE | 12 month MACE | 18 +/- 16/12 MACE | 3 year MACE | Survival at five year |
|---|---|---|---|---|---|---|---|---|---|
Herz et al. | Conventional OPCAB using LIMA | 386 | 2.8% Bleeding | 1% Mortality | |||||
8.5% AF | |||||||||
6 days MLOHS | 2% TVR | ||||||||
Vassiliades et al. | Endo-ACAB using LIMA | 607 | 1% Mortality | 1.6% Bleeding | 2% Mortality | 92% | |||
1.6% MI | 19.6% AF | 2.1% MI | |||||||
0.3% Stroke | 11 days MLOHS | 0.8% Stroke | |||||||
1.5% TVR | 3.6% Conversion to sternotomy | 0.7% TVR | |||||||
9% Respiratory complications | |||||||||
Kappert et al. | TECAB | 41 | 92.7% | ||||||
Kapoor et al. | PCI vs. Standard CABG using LIMA | 633 vs. 577 | 1% Mortality for both | 0.3 vs. 2.1% Mortality | 92.8 vs. 90.6% | ||||
19.5 vs. 4% TVR | |||||||||
Bonatti et al. | TECAB | 334 | 0.3% Mortality | 95.8% | |||||
Halkos et al. | Sternotomy vs. Minimal invasive Non-sternotomy using LIMA | 234 vs. 363 | 1.1 vs. 0.9% Mortality | ||||||
1.4 vs. 0.4% MI | |||||||||
0 vs. 1.3% Stroke | |||||||||
2.2 vs. 2.6% MACE | |||||||||
Casula et al. | Robotic enhanced using LIMA | 100 | 0% Mortality | 0% Bleeding | 0% Mortality | 0% Mortality | 3% Mortality | 96% | |
2% AF | |||||||||
0% MI | 4 days | 0% MI | 2% | ||||||
0% Stroke | MLOHS | 0% Stroke | MI | ||||||
3.0% | 0% TVR | 1% Stroke | |||||||
0% TVR | Conversion to | ||||||||
MIDCAB | 3% TVR | ||||||||
4% Respiratory complications |